瑞康医药：累计回购约2361.31万股

Group 1 - The core point of the article is that Ruikang Pharmaceutical announced a share buyback plan, intending to repurchase approximately 23.61 million shares, which represents 1.57% of the company's total share capital, with a total transaction amount of 69.39 million yuan [1][1][1] - The share buyback will occur through a centralized bidding method, with the highest transaction price set at 3.08 yuan per share and the lowest at 2.75 yuan per share [1][1][1] - As of the report, Ruikang Pharmaceutical's market capitalization stands at 4.3 billion yuan [1][1][1] Group 2 - For the first half of 2025, Ruikang Pharmaceutical's revenue composition shows that sales of pharmaceuticals and medical devices account for 98.42%, mobile healthcare for 0.67%, other sources for 0.6%, and leasing for 0.31% [1][1][1]